ロード中...
MBCL-52. ENDOCRINE PROFILE AFTER MEDULLOBLASTOMA TREATMENT
BACKGROUND: Treatment of medulloblastoma has evolved substantially with more chemotherapy, risk-adapted dosing of radiotherapy (RT) and new RT techniques. We present the endocrine profile for our patients treated over a 20-year period. METHODS: The charts of patients treated for medulloblastoma betw...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7715513/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.521 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|